Rubedo Life Sciences
Rubedo Life Sciences is a biopharmaceutical company that is developing a diverse portfolio of innovative therapies that are engineered to target cells that are responsible for chronic age-related diseases. Its proprietary ALEMBIC drug discovery platform has generated novel first-in-class small molecules designed to selectively target senescent cells, which are important in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic, and other chronic diseases. The Rubedo leadership team is made up of industry leaders and pioneers in chemistry, technology, and life sciences, with extensive experience in drug development and commercialization ranging from large pharma to biotech innovators.
Domain
rubedolife.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$40.0M
Founded
2017
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Rubedo Life Sciences use?+
Rubedo Life Sciences uses 19 technologies including Elementor, Google Analytics, Google Tag Manager.
What industry is Rubedo Life Sciences in?+
Rubedo Life Sciences operates in the Biotechnology industry.
Where is Rubedo Life Sciences based?+
Rubedo Life Sciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026